Online citations, reference lists, and bibliographies.
← Back to Search

A Phase II Clinical Trial Of The Vascular Disrupting Agent BNC105P As Second Line Chemotherapy For Advanced Malignant Pleural Mesothelioma

Anna K. Nowak, Chris Brown, Michael J. Millward, Jenette Creaney, Michael J. Byrne, Brett Hughes, Gabriel Kremmidiotis, David C. Bibby, Annabell F. Leske, Paul L.R. Mitchell, Nick Pavlakis, Michael Boyer, Martin R. Stockler

Save to my Library
Download PDF
Analyze on Scholarcy
Share